Thermo Fisher

Thermo Fisher will drop a whopping $600M into its manufacturing supply chain as Covid-19 work ramps up
Thermo Fisher will drop a whopping $600M into its manufacturing supply chain as Covid-19 work ramps up
Endpoints
Thermo Fisher
COVID-19
CDMOs
Flag link:
Medtech’s haves and have-nots
Medtech’s haves and have-nots
EP Vantage
earnings
devices
Medtech
Medtronic
EXACT Sciences
Thermo Fisher
Abbott Labs
Roche
Qiagen
JNJ
Zimmer Biomet
Smith & Nephew
Boston Scientific
Flag link:
How Thermo Fisher Scientific Beat Wall Street Estimates in Q4
How Thermo Fisher Scientific Beat Wall Street Estimates in Q4
Motley Fool
Thermo Fisher
earnings
COVID-19
diagnostics
Flag link:
Big Deals Keep on Turning and the Medtech Spend Keeps on Burning
Big Deals Keep on Turning and the Medtech Spend Keeps on Burning
Medical Devices and Diagnostics Industry
M&A
Medtech
devices
Obalon Therapeutics
ReShape
Boston Scientific
Preventice
Thermo Fisher
Mesa Biotech
Hill-Rom
Bardy Diagnostics
Flag link:
Thermo Fisher Takes Deep Dive into Cell and Gene Therapy with Viral Vector Business Buy
Thermo Fisher Takes Deep Dive into Cell and Gene Therapy with Viral Vector Business Buy
BioSpace
Thermo Fisher
cell therapy
gene therapy
viral vector
Henogen AS
Flag link:
Continuing rapid expansion, Thermo Fisher says it will add on plasmid DNA manufacturing site in California
Continuing rapid expansion, Thermo Fisher says it will add on plasmid DNA manufacturing site in California
Endpoints
Thermo Fisher
CDMOs
California
Flag link:
Thermo Fisher aims to boost its clinical offerings with German expansion — including cold chain for the Covid-19 effort
Thermo Fisher aims to boost its clinical offerings with German expansion — including cold chain for the Covid-19 effort
Endpoints
Thermo Fisher
supply chain
CDMOs
COVID-19
Germany
Flag link:
Looking for an edge in vaccines, Thermo Fisher plots major expansions across global manufacturing sites in its portfolio
Looking for an edge in vaccines, Thermo Fisher plots major expansions across global manufacturing sites in its portfolio
Endpoints
Thermo Fisher
CDMO
drug manufacturing
vaccines
COVID-19
Flag link:
Thermo sees ‘very, very’ significant cold-chain demand as COVID-19 vaccines enter endgame
Thermo sees ‘very, very’ significant cold-chain demand as COVID-19 vaccines enter endgame
Biopharma Reporter
Thermo Fisher
COVID-19
vaccines
pandemic
distribution
logistics
Flag link:
FDA warns on false results for Thermo Fisher TaqPath COVID-19 testing kit
FDA warns on false results for Thermo Fisher TaqPath COVID-19 testing kit
Mass Device
Thermo Fisher
TaqPath
COVID-19
diagnostics
Flag link:
Will the Thermo Fisher Scientific and Qiagen Merger Still Happen?
Will the Thermo Fisher Scientific and Qiagen Merger Still Happen?
Medical Devices and Diagnostics Industry
devices
M&A
Thermo Fisher
Qiagen
Flag link:
Daiichi Sankyo and Thermo Fisher Partner on Companion Diagnostic Device for NSCLC
Daiichi Sankyo and Thermo Fisher Partner on Companion Diagnostic Device for NSCLC
BioSpace
Daiichi Sankyo
Thermo Fisher
companion diagnostics
diagnostics
non-small cell lung cancer
Flag link:
Thermo Fisher continues global expansion push with CSL Behring biologics plant lease
Thermo Fisher continues global expansion push with CSL Behring biologics plant lease
Fierce Pharma
Thermo Fisher
CSL Behring
Switzerland
biologics
Flag link:
Thermo Fisher Scientific inks COVID-19 test tube deal with U.S. government
Thermo Fisher Scientific inks COVID-19 test tube deal with U.S. government
Fierce Pharma
Thermo Fisher
government contract
medical supplies
pandemic
federal government
COVID-19
Flag link:
Thermo Fisher to invest $180M in new gene therapy plant
Thermo Fisher to invest $180M in new gene therapy plant
BioPharma Dive
Thermo Fisher
gene therapy
Flag link:
Thermo Fisher and Roche enjoy COVID-19 diagnostic tailwinds, but warn of routine testing declines
Thermo Fisher and Roche enjoy COVID-19 diagnostic tailwinds, but warn of routine testing declines
Medtech Dive
devices
Medtech
diagnostics
Thermo Fisher
Roche
COVID-19
Flag link:
A Covid-19 threat to business acquisitions
A Covid-19 threat to business acquisitions
EP Vantage
COVID-19
M&A
AbbVie
Allergan
Arya Sciences
Immatics
AcelRx
Tetraphase
Gilead Sciences
Forty Seven
Thermo Fisher
Stryker
Wright Medical
Flag link:
Thermo Fisher to produce millions of coronavirus diagnostic tests
Thermo Fisher to produce millions of coronavirus diagnostic tests
Stat
Thermo Fisher
diagnostics
coronaviruses
COVID-19
Flag link:
Thermo Fisher & J&J Team Up to Develop Lung Cancer Companion Diagnostic
Thermo Fisher & J&J Team Up to Develop Lung Cancer Companion Diagnostic
BioSpace
JNJ
Janssen
Thermo Fisher
diagnostics
cancer
clinical trials
Flag link:
Thermo Fisher Rumored to Be Interested in Acquiring Qiagen
Thermo Fisher Rumored to Be Interested in Acquiring Qiagen
Medical Devices and Diagnostics Industry
devices
Thermo Fisher
Qiagen
M&A
Flag link:

Pages